Federal Court of Appeal affirms paliperidone palmitate claims are not unpatentable methods of medical treatment | Smart & Biggar

In a 2022 decision involving Janssen and Pharmascience, the Federal Court found that the claims of Canadian Patent No. 2,655,335 (335 patent, relating to paliperidone palmitate...

Related Keywords

Canada ,Canadian , ,Supreme Court ,Pharmascience Incv Janssen Inc ,Federal Court ,Canadian Patent ,Pharmascience Inc ,Janssen Inc ,